Related references
Note: Only part of the references are listed.Using marginal structural models to adjust for treatment drop-in when developing clinical prediction models
Matthew Sperrin et al.
STATISTICS IN MEDICINE (2018)
Adjusting for treatment switching in randomised controlled trials - A simulation study and a simplified two-stage method
Nicholas R. Latimer et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2017)
Accounting for treatment use when validating a prognostic model: a simulation study
Romin Pajouheshnia et al.
BMC MEDICAL RESEARCH METHODOLOGY (2017)
Prediction models in obstetrics: understanding the treatment paradox and potential solutions to the threat it poses
F. Cheong-See et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2016)
Beta-blockers in COPD: time for reappraisal
Brian Lipworth et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Explicit inclusion of treatment in prognostic modeling was recommended in observational and randomized settings
Rolf H. H. Groenwold et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
Karel G. M. Moons et al.
ANNALS OF INTERNAL MEDICINE (2015)
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
Peter C. Austin et al.
STATISTICS IN MEDICINE (2015)
Beta-Blockers Reduced the Risk of Mortality and Exacerbation in Patients with COPD: A Meta-Analysis of Observational Studies
Qingxia Du et al.
PLOS ONE (2014)
Beta-blocker use and COPD mortality: a systematic review and meta-analysis
Mahyar Etminan et al.
BMC PULMONARY MEDICINE (2012)
Cardiovascular risk scores do not account for the effect of treatment: a review
S. M. Liew et al.
HEART (2011)
β-Blockers May Reduce Mortality and Risk of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease
Frans H. Rutten et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes
Linda E. Levesque et al.
BRITISH MEDICAL JOURNAL (2010)
Constructing inverse probability weights for marginal structural models
Stephen R. Cole et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Predictors of Mortality in Patients with Stable COPD
Cristobal Esteban et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2008)
Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study
FH Rutten et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
A structural approach to selection bias
MA Hernán et al.
EPIDEMIOLOGY (2004)
Marginal structural models and causal inference in epidemiology
JM Robins et al.
EPIDEMIOLOGY (2000)
Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests
JM Robins et al.
BIOMETRICS (2000)
Share Paper
